V

Verrica Pharmaceuticals
D

VRCA

1.12500
USD
0.13
(13.01%)
Market Closed
Volume
39,366
EPS
-1
Div Yield
-
P/E
-1
Market Cap
101,885,445
News

Title: Verrica Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.